These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 11858170

  • 1. N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease.
    Agúndez JA, Ladero JM, Olivera M, Lozano L, Fernández-Arquero M, de laConcha EG, Díaz-Rubio M, Benitez J.
    Scand J Gastroenterol; 2002 Jan; 37(1):99-103. PubMed ID: 11858170
    [Abstract] [Full Text] [Related]

  • 2. Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)--an investigation in a department of surgical medicine.
    Farker K, Schotte U, Scheele J, Hoffmann A.
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):387-91. PubMed ID: 12877350
    [Abstract] [Full Text] [Related]

  • 3. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
    Nischalke HD, Lutz P, Krämer B, Söhne J, Müller T, Rosendahl J, Fischer J, Berg T, Hittatiya K, Fischer HP, Soyka M, Semmo N, Nattermann J, Sauerbruch T, Strassburg CP, Stickel F, Spengler U.
    J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
    [Abstract] [Full Text] [Related]

  • 4. [Relationship between genetic polymorphisms of N-acetyltransferase and susceptibility to hepatocellular carcinoma].
    Gao JP, Huang YD, Lin JA, Zhu QC, Liang JP.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):20-2. PubMed ID: 12546735
    [Abstract] [Full Text] [Related]

  • 5. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
    Fabris C, Toniutto P, Falleti E, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Fumolo E, Avellini C, Minisini R, Pirisi M.
    Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
    [Abstract] [Full Text] [Related]

  • 6. Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers.
    Agúndez JA, Olivera M, Ladero JM, Rodriguez-Lescure A, Ledesma MC, Diaz-Rubio M, Meyer UA, Benítez J.
    Pharmacogenetics; 1996 Dec; 6(6):501-12. PubMed ID: 9014199
    [Abstract] [Full Text] [Related]

  • 7. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C, Washio M, Horiuchi T, Tada Y, Asami T, Ide S, Takahashi H, Kobashi G, Kyushu Sapporo SLE (KYSS) Study Group.
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [Abstract] [Full Text] [Related]

  • 8. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients.
    Nezi V, Deutsch M, Gazouli M, Alexopoulou A, Paparrigopoulos T, Liappas IA, Dourakis SP.
    Alcohol Clin Exp Res; 2013 Feb; 37(2):244-51. PubMed ID: 23009036
    [Abstract] [Full Text] [Related]

  • 9. Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma.
    Huang YS, Chern HD, Wu JC, Chao Y, Huang YH, Chang FY, Lee SD.
    Am J Gastroenterol; 2003 Jun; 98(6):1417-22. PubMed ID: 12818290
    [Abstract] [Full Text] [Related]

  • 10. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.
    Ladero JM, Agúndez JA, Olivera M, Lozano L, Rodríguez-Lescure A, Diaz-Rubio M, Benítez J.
    Eur J Clin Pharmacol; 2002 May; 58(2):115-8. PubMed ID: 12012143
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L, Silvestri L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Bottelli R, Mondelli MU, Civardi E, Silini EM.
    Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
    [Abstract] [Full Text] [Related]

  • 12. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E, Fabris C, Cmet S, Cussigh A, Bitetto D, Fontanini E, Fornasiere E, Bignulin S, Fumolo E, Bignulin E, Pirisi M, Toniutto P.
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [Abstract] [Full Text] [Related]

  • 13. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H, Sigsgaard T, Wolf H, Autrup H.
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [Abstract] [Full Text] [Related]

  • 14. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
    Costa S, Medeiros R, Vasconcelos A, Pinto D, Lopes C.
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E, Shaker O, Abd El Aziz G, Ramadan H, Esmat G.
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [Abstract] [Full Text] [Related]

  • 16. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Trinchet JC, Beaugrand M, Charnaux N, Nahon P.
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H, Bayram S, Bekar A, Akgöllü E, Ulger Y.
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.